Contributing to therapeutic drug development using Amazon Managed Blockchain
Blog
This article discusses how Susmed is using Amazon Managed Blockchain to improve clinical trial processes in the pharmaceutical industry by addressing key challenges:
- High costs of clinical research and trials
- Risk of data falsification and misrepresentation
- Need for more transparent and secure research methods
Key blockchain implementation highlights include:
- Collaboration with Aculys Pharma for first corporate clinical trial blockchain solution
- Demonstrating data reliability through tamper-resistant blockchain technology
- Reducing R&D costs and improving data monitoring accuracy
- Using a consortium blockchain with controlled participant access
The solution leverages AWS services to create a serverless, flexible architecture that enables efficient and secure clinical trial management.
The AWS News Feed is currently looking for gold sponsors. If you want to support the AWS community and reach a large audience of AWS professionals, consider sponsoring the AWS News Feed.
Related articles
Jan 2
2025
2025
Build with blockchain data using Amazon Managed Blockchain and ZettaBlock
Sep 27
2024
2024
Getting drugs to market faster through better health data management on AWS
Nov 1
2024
2024
Advance environmental sustainability in clinical trials using AWS
Oct 7
2024
2024
Accelerating Drug Discovery with AWS HealthOmics and NVIDIA Blueprints
The AWS News Feed is currently looking for silver sponsors. If you want to support the AWS community and reach a large audience of AWS professionals, consider sponsoring the AWS News Feed.